Skip to main content
. 2022 Jun 1;112(1):75–86. doi: 10.1007/s00392-022-02036-9

Table 4.

Correlation between congestion markers on admission and at discharge

Hospital admission
CS IVCmax VAS NT-proBNP
CS 0.09 (− 0.08 to 0.26) 0.04 (− 0.14 to 0.22) − 0.07 (− 0.24 to 0.101)
IVCmax 0.09 (− 0.08 to 0.26) 0.11 (− 0.07 to 0.28) − 0.09 (− 0.25 to 0.09)
VAS 0.04 (− 0.14 to 0.22) 0.11 (− 0.07 to 0.28) 0.04 (− 0.13 to 0.22)
NT-proBNP − 0.07 (− 0.24 to 0.101) − 0.09 (− 0.25 to 0.09) 0.04 (− 0.13 to 0.22)
Hospital discharge
CS IVCmax DVAS NT-proBNP
 CS 0.17 (− 0.01 to 0.34) 0.02 (− 0.16 to 0.2) 0.17 (− 0.02 to 0.347)
 IVCmax 0.17 (− 0.01 to 0.34) 0.12 (− 0.06 to 0.29) 0.05 (− 0.13 to 0.24)
 DVAS 0.02 (− 0.16 to 0.2) 0.12 (− 0.06 to 0.29) 0.05 (− 0.13 to 0.23)
 NT-proBNP 0.17 (− 0.02 to 0.347) 0.05 (− 0.13 to 0.24) 0.05 (− 0.13 to 0.23)

Spearman correlation coefficients and respective 95% confidence intervals for congestion marker measures at hospital admission and at hospital discharge based on multiple imputed data. CS clinical congestion score, IVCmax maximum inferior vena cava diameter, NT-proBNP  N-terminal pro-B-type natriuretic peptide, DVAS   visual analogue scale for dyspnea